Reliefband set to launch Reliefband Neurowave in early 2017
LAS VEGAS — Reliefband Technologies on Tuesday unveiled its Reliefband Neurowave for the drug-free relief from nausea, retching and vomiting caused by morning sickness and motion sickness, including the motion sickness associated with VR SIM.
"For the 60 million Americans who frequently suffer with motion sickness and the nearly 80% of women who experience morning sickness during pregnancy, the Reliefband Neurowave is simply life-changing," stated Nick Spring, CEO Reliefband Technologies. "The Reliefband Neurowave was developed in response to customers who told us they had given up hope of controlling their nausea," he said. "We wanted to help those who are sick of feeling sick by making a drug-free device that is easy-to-use and elegant to wear over long periods. This way they can start living their lives without the worry, embarrassment, discomfort and inconvenience nausea can bring."
The device allows users to travel without fear of sickness from many common leisure pursuits such as cruising, fishing, amusement rides or staying in the VR game. It will be commercially available in the second quarter of 2017 and will be priced around $150.
The Reliefband Neurowave applies accurately programmed pulses with highly specific waveforms, frequency and intensity to modulate the median nerve on the underside of the wrist. This precise activity (technically referred to as "neuromodulation") uses the body's natural neural pathways to block the waves of nausea produced by the stomach.